NetScientific plc (LON:NSCI – Get Free Report)’s stock price traded down 1.7% during trading on Thursday . The company traded as low as GBX 58.20 ($0.74) and last traded at GBX 59 ($0.75). 8,339 shares were traded during mid-day trading, a decline of 36% from the average session volume of 13,096 shares. The stock had […]
NetScientific plc (LON:NSCI – Get Free Report)’s stock price reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 49 ($0.60) and last traded at GBX 49.50 ($0.60), with a volume of 64429 shares trading hands. The stock had previously closed at GBX 53.50 ($0.65). NetScientific Stock Performance […]
The easiest way to describe NetScientific PLC (LON:NSCI) is a ‘reset story’. By this I mean new management has come in, cut costs, refinanced, refocused, and, hopefully, put the business back on the guide rails to success.
Like all reset stories, it will take the market a while to absorb what has occurred and appropriately value the business, which invests in technology and life sciences companies.
While that may be a short-term inconvenience for management, it might also provide an opportunity for eagle-eyed investors.
Shrewd stock pickers will already have spied a screaming anomaly.
One single investment, the firm’s holding in PDS Biotechnology, is currently worth £10mln, or 95% of NetScientific’s current market capitalisation. We’ll explore PDS in greater depth later on.